Malats N - Search Results

1

GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery.

van Eijck CWF, Real FX, Malats N, Vadgama D, van den Bosch TPP, Doukas M, van Eijck CHJ, Mustafa DAM; Dutch Pancreatic Cancer Group (DPCG). van Eijck CWF, et al. Among authors: malats n. Cell Rep Med. 2024 May 21;5(5):101557. doi: 10.1016/j.xcrm.2024.101557. Epub 2024 May 10. Cell Rep Med. 2024. PMID: 38733987 Free PMC article.

2

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.

Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Malats N, et al. J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679. J Clin Oncol. 1995. PMID: 7602358

3

Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.

Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Porta M, et al. Among authors: malats n. J Clin Epidemiol. 1994 Sep;47(9):1069-79. doi: 10.1016/0895-4356(94)90123-6. J Clin Epidemiol. 1994. PMID: 7730910

4

DDT and pancreatic cancer.

Malats N, Real FX, Porta M. Malats N, et al. J Natl Cancer Inst. 1993 Feb 17;85(4):328-9. doi: 10.1093/jnci/85.4.328. J Natl Cancer Inst. 1993. PMID: 8426376 No abstract available.

5

Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.

Malats N, Porta M, Corominas JM, Piñol JL, Rifà J, Real FX. Malats N, et al. Int J Cancer. 1997 Mar 17;70(6):661-7. doi: 10.1002/(sici)1097-0215(19970317)70:6<661::aid-ijc6>3.0.co;2-t. Int J Cancer. 1997. PMID: 9096646

6

Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer.

Soler M, Porta M, Malats N, Guarner L, Costafreda S, Gubern JM, García-Olivares E, Andreu M, Real FX. Soler M, et al. Among authors: malats n. J Clin Epidemiol. 1998 Dec;51(12):1215-21. doi: 10.1016/s0895-4356(98)00130-9. J Clin Epidemiol. 1998. PMID: 10086813

7

Human cancer, carcinogenic exposures and mutation spectra.

Vineis P, Malats N, Porta M, Real FX. Vineis P, et al. Among authors: malats n. Mutat Res. 1999 Mar;436(2):185-94. Mutat Res. 1999. PMID: 10095140 Review. No abstract available.

8

Correction: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Malats N, Real FX. Malats N, et al. N Engl J Med. 1999 May 20;340(20):1592-3. doi: 10.1056/NEJM199905203402014. N Engl J Med. 1999. PMID: 10336360 Free article. No abstract available.

9

Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.

Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Malats N, et al. Gut. 2001 Jan;48(1):70-4. doi: 10.1136/gut.48.1.70. Gut. 2001. PMID: 11115825 Free PMC article.

10

Generalizing molecular results arising from incomplete biological samples: expected bias and unexpected findings.

Porta M, Malats N, Corominas JM, Rifà J, Piñol JL, Real FX; Pankras I Project Investigators. Porta M, et al. Among authors: malats n. Ann Epidemiol. 2002 Jan;12(1):7-14. doi: 10.1016/s1047-2797(01)00267-8. Ann Epidemiol. 2002. PMID: 11750234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters